May 15th: 1. We own all trial data. 2. O
Post# of 151967

1. We own all trial data.
2. Officially elevated above the optics of being another Hiv combo company.
3. Only company to validate a large molecule / CCR5 / CCL5 in 3rd party papers & trials -- years of each.
4. Validates Leronlimab's lack of SAE's as related to future 1600 patient manuscript.
5. Validates our iP --- that value alone is staggering upon MOA showing the paradim shift potential.

